Recognition of serum alkaline phosphatase by murine monoclonal antibodies against human osteosarcoma cells. 1986

C Tanaka, and T Yamamuro, and T Masuda, and H Tanaka, and M Matsumoto, and Y Kotoura, and T Tsuji, and J Toguchida, and M Miyama-Inaba, and M Ueda

Using OST6 and OST7 monoclonal antibodies against human osteosarcoma cells, a solid-phase radioimmunosandwich assay was developed to quantitate a human osterosarcoma-associated antigen in a total of 242 sera from healthy adults and patients with various diseases. The levels of the antigen in sera were high in patients with osteosarcoma and in children without tumorous diseases compared with healthy adults; however, the highest level of the antigen was found in patients with obstructive jaundice. The quantity of the antigen correlated with serum alkaline phosphatase (EC 3.1.3.1.) activity, and showed a strong correlation (correlation coefficient, 0.94) in 50 sera. Immunolocalization of enzyme activity assay using monoclonal antibodies was performed to ascertain whether the antigen had alkaline phosphatase activity. This assay proved that OST6, OST7, and OST15 monoclonal antibodies recognized serum alkaline phosphatase; furthermore, these monoclonal antibodies seemed to react with not only the bone isoenzyme but also the liver isoenzyme.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma

Related Publications

C Tanaka, and T Yamamuro, and T Masuda, and H Tanaka, and M Matsumoto, and Y Kotoura, and T Tsuji, and J Toguchida, and M Miyama-Inaba, and M Ueda
July 1991, Japanese journal of cancer research : Gann,
C Tanaka, and T Yamamuro, and T Masuda, and H Tanaka, and M Matsumoto, and Y Kotoura, and T Tsuji, and J Toguchida, and M Miyama-Inaba, and M Ueda
December 1987, Biochemistry and cell biology = Biochimie et biologie cellulaire,
C Tanaka, and T Yamamuro, and T Masuda, and H Tanaka, and M Matsumoto, and Y Kotoura, and T Tsuji, and J Toguchida, and M Miyama-Inaba, and M Ueda
January 1991, International orthopaedics,
C Tanaka, and T Yamamuro, and T Masuda, and H Tanaka, and M Matsumoto, and Y Kotoura, and T Tsuji, and J Toguchida, and M Miyama-Inaba, and M Ueda
October 1976, Journal of the National Cancer Institute,
C Tanaka, and T Yamamuro, and T Masuda, and H Tanaka, and M Matsumoto, and Y Kotoura, and T Tsuji, and J Toguchida, and M Miyama-Inaba, and M Ueda
January 1983, American journal of human genetics,
C Tanaka, and T Yamamuro, and T Masuda, and H Tanaka, and M Matsumoto, and Y Kotoura, and T Tsuji, and J Toguchida, and M Miyama-Inaba, and M Ueda
October 1991, Biokhimiia (Moscow, Russia),
C Tanaka, and T Yamamuro, and T Masuda, and H Tanaka, and M Matsumoto, and Y Kotoura, and T Tsuji, and J Toguchida, and M Miyama-Inaba, and M Ueda
January 1994, European journal of cancer (Oxford, England : 1990),
C Tanaka, and T Yamamuro, and T Masuda, and H Tanaka, and M Matsumoto, and Y Kotoura, and T Tsuji, and J Toguchida, and M Miyama-Inaba, and M Ueda
January 1983, Clinical chemistry,
C Tanaka, and T Yamamuro, and T Masuda, and H Tanaka, and M Matsumoto, and Y Kotoura, and T Tsuji, and J Toguchida, and M Miyama-Inaba, and M Ueda
January 1989, Andrologia,
C Tanaka, and T Yamamuro, and T Masuda, and H Tanaka, and M Matsumoto, and Y Kotoura, and T Tsuji, and J Toguchida, and M Miyama-Inaba, and M Ueda
May 1989, Journal of clinical microbiology,
Copied contents to your clipboard!